Abstract
In recent years, the oxidative stress-induced free radicals have been implicated in the pathogenesis of type 1 diabetes mellitus (DM). It has been also reported that elements like selenium (Se), zinc (Zn), and copper (Cu) involved in lipid peroxidation may play a role in the pathogenesis and exacerbation of this disease. The aim of the present study was to evaluate the antioxidant status and micronutrient levels in children with type 1 DM. The study included 35 children with type 1 DM (16 girls and 19 boys) with a mean age of 13.8 ± 4.5 years and a mean disease duration of 3.6 ± 2.8 years and 26 age-matched healthy children (11 girls and 15 boys) with a mean age of 12.8 ± 3.3 years. The Se and Zn levels of children with type 1 DM were significantly lower than those of controls. Glycosylated hemoglobin (HbA1c) levels were found to be inversely correlated with Se and Zn levels. There was no any statistically significant difference between serum Cu levels of patients with type 1 DM and controls. Glutathione peroxidase (GSH-Px) levels were lower in patients with type 1 DM when compared with those of controls, and there was a negative correlation between HbA1c and GSH-Px levels. We believe that the increased oxidative stress may be originated from low levels of glutathione peroxidase resulted from decreased levels of Se. The negative correlation between Se, Zn, GSH-Px, and HbA1c levels may show poor metabolic control of the disease and effect of oxidative injury. Those elements should be closely monitored during the course of type 1 DM, and supplementation of these elements may be beneficial both for controlling diabetes and preventing long-term oxidative injury related to diabetic complications.
Similar content being viewed by others
References
Maritim AC, Sanders RA, Watkins 3rd JB. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003;17(1):24–38.
Ceriello A. Oxidative stress and glycemic regulation. Metabolism. 2000;49(2(Suppl 1)):27–9.
Rayman MP. The importance of selenium to human health. Lancet. 2000;356(9225):233–41.
Ruiz C, Alegria A, Barbera R, Farre R, Lagarda J. Selenium, zinc and copper in plasma of patients with type 1 diabetes mellitus in different metabolic control states. J Trace Elem Med Biol. 1998;12(2):91–5.
Rph T. Alcohol, nutrition, and the liver. Eur J Gastroenterol Hepatol. 1990;2:417–21.
Martín-Gallán P, Carrascosa A, Gussinyé M, Domínguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med. 2003;34(12):1563–74.
Selvin E, Rawlings AM, Grams M, Klein R, Sharrett AR, Steffes M, et al. Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol. 2014;4:279–88. doi:10.1016/S2213-8587(13)70199-2.
Kljai K, Runje R. Selenium and glycogen levels in diabetic patients. Biol Trace Elem Res. 2001;83(3):223–9.
L’Abbe MR, Trick KD. Changes in pancreatic glutathione peroxidase and superoxide dismutase activities in the prediabetic diabetes-prone BB rat. Proc Soc Exp Biol Med. 1994;207(2):206–12.
Kostolanska J, Jakus V, Barak L. HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2009;22(5):433–42.
Kljai K, Runje R. Selenium and glycogen levels in diabetic patients. Biol Trace Elem Res. 2001;83:223–9.
Zbronska H, Grzeszczak W, Jendryczko A, Zbronski R, Kuzniewicz R. Activity of superoxide dismutase in erythrocytes and leukocytes and levels of zinc and copper in blood of patients with diabetes. Effect of diabetic treatment on examined parameters. Pol Arch Med Wewn. 1995;94(3):228–34.
Basaki M, Saeb M, Nazifi S, Shamsaei HA. Zinc, copper, iron, and chromium concentrations in young patients with type 2 diabetes mellitus. Biol Trace Elem Res. 2012;148(2):161–4.
Akinloye O, Ogunleye K, Oguntibeju OO. Cadmium, lead, arsenic and selenium levels in patients with type 2 diabetes mellitus. Afr J Biotechnol. 2010;9:5189–95.
Tabar MB. Determination of serum selenium in patients with type II diabetes mellitus. Middle-East J Sci Res. 2012;12:433–5.
Asare GA, Osae S, Nortey ENN, Yambire FK, Amedonu E, Doku D, et al. Evaluation of serum metallothionein-1, selenium, zinc, and copper in Ghanaian type 2 diabetes mellitus patients. Int J Diabetes Dev Ctries. 2013;33:86–95.
Vinceti M, Maraldi T, Bergomi M, Malagoli C. Risk of chronic low-dose selenium overexposure in humans: insights from epidemiology and biochemistry. Rev Environ Health. 2009;24(3):231–48.
Kinlaw WB, Levine AS, Morley JE, Silvis SE, McClain CJ. Abnormal zinc metabolism in type II diabetes mellitus. Am J Med. 1983;75(2):273–7.
Bideci A, Camurdan MO, Cinaz P, Dursun H, Demirel F. Serum zinc, insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab. 2005;18(10):1007–11.
Kumar S, Rao KS. Bood and urinary zinc levels in diabetes mellitus. Nutr Metab. 1974;17(4):231–5.
Levine AS, McClain CJ, Handwerger BS, Brown DM, Morley JE. Tissue zinc status of genetically diabetic and streptozotocin-induced diabetic mice. Am J Clin Nutr. 1983;37(3):382–6.
Duzguner V, Kaya S. Effect of zinc on the lipid peroxidation and the antioxidant defense systems of the alloxan-induced diabetic rabbits. Free Radic Biol Med. 2007;42(10):1481–6.
Kazi TG, Afridi HI, Kazi N, Jamali MK, Arain MB, Jalbani N, et al. Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol Trace Elem Res. 2008;122:1–18.
Olaniyan OO, Awonuga MAM, Ajetunmobi AF, Adeleke IA, Fagbolade OJ, Olabiyi KO, et al. Serum copper and zinc levels in Nigerian type 2 diabetic patients. Afr J Diabetes Med. 2012;20:36–8.
Serdar MA, Bakir F, Haşimi A, Çelik T, Akin O, Kenar L, et al. Trace and toxic element patterns in nonsmoker patients with noninsulin-dependent diabetes mellitus, impaired glucose tolerance, and fasting glucose. Int J Diabetes Dev Ctries. 2009;29:35–40.
Evliyaoğlu O, Kebapçılar L, Uzuncan N, Kılıçaslan N, Karaca B, Kocaçelebi R, et al. Correlations of serum Cu+2, Zn+2, Mg+2 and HbA1c in type 2 and type 2 diabetes mellitus. Turk J Endocrinol Metab. 2004;2:75–9.
Ekmekcioglu C, Prohaska C, Pomazal K, Steffan I, Schernthaner G, Marktl W. Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls. Biol Trace Elem Res. 2001;79:205–9.
Viktorínováa A, Tošerováb E, Križkob M, Ďuračková Z. Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus. Metabolism. 2009;58:1477–82.
Lajunen LHJ. Spectrochemical analysis by atomic absorption and emission. Cambridge: The Royal Society of Chemistry; 1992.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Özenç, S., Saldir, M., Sarı, E. et al. Selenium, zinc, and copper levels and their relation with HbA1c status in children with type 1 diabetes mellitus. Int J Diabetes Dev Ctries 35, 514–518 (2015). https://doi.org/10.1007/s13410-015-0327-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-015-0327-y